advocacy

The Research!America 2021 Virtual Advocacy Awards program featured recognition of several of the 2020 awardees we were unable to salute in March 2020 due to the COVID-19 pandemic. Herbert Pardes, Executive Vice Chairman of Board of Trustees, NewYork-Presbyterian Hospital, and Research!America board member, introduced the speakers and extended his thanks. “I want to thank you all for your respective contributions to science and health. We've never needed you more than now,” he said. Stephen Rosenfeld, MD, President, Freeport Research Systems, and President, Rosenfeld Heart Foundation, led these remarkable advocates, scientists, and researchers in a discussion intended to allow the audience...
As we celebrate Pride Month, it is important to recognize lesbian, gay, bisexual, transgender, and queer (LGBTQ+) individuals who are making a difference for science and society. The courage to be visible is vital; it gives people role models, encourages freedom of expression, and opens a dialogue of inclusion across cultures. A testament to the power of visability and advocating for others, neuroscientist Ben Barres, MD, PhD, was an openly transgender scientist and ardent advocate for early-career scientists and for equal opportunity for gender and sexual minorities in the sciences. Credited with the revolutionary discovery of the crucial roles played by glial cells (supportive cells in...
The Activist Lab at the University of South Florida College of Public Health serves as a resource for students to develop skills and gain experience in advocacy, education, research, leadership, and service. For their 2021 Civic Engagement Microgrant project, the Activist Lab developed a new podcast series to highlight topics related to environmental health, climate change, and advocacy. Join us below to learn more about the Activist Lab and its graduate student leader, Rolando Trejos Saucedo. Please tell us about your microgrant project. Our microgrant project includes a new podcast series, Advocation-Change it Up , consisting of five episodes on environmental health, climate change, and...
How are research advocates making their case on Capitol Hill during COVID-19? I had the opportunity to find out recently when the Washington Fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET) visited congressional offices - virtually. I served as a mentor to a group of early career scientists participating in the ASPET Hill Day for the first time. Our goals were two-fold: to champion NIH and NSF funding by asking congressional offices to sign Dear Colleague Letters, and to discuss the essential use of animals in biomedical research in order to develop therapies for improving human and veterinary health. Normally, fellows would be in Washington, DC, for a...
With 2020 in our rearview mirror, we’re taking a look back at our 10 most popular blog posts (based on page views) for the year. The posts cover a wide range of topics including basic and clinical research, public health, clinical trials, and the impacts of COVID-19. We thank our distinguished group of guest bloggers including young researchers, academics, industry experts, public health professionals, and patient advocates as well as the staff here at Research!America who are united in support for stronger investments in research and innovation to combat diseases and build a safer, stronger, healthier nation. 1) Explained: How a COVID-19 Serology Test Works and Obstacles to its Use May 19...
For more than 30 years, the organizations that constitute the Research!America alliance – patient advocates, research universities, independent research institutes, academic health centers, scientific societies, biomedical, medical technology and data companies, philanthropies, and more – have fought hard and successfully for life-saving progress. During a year in which alliance members were called to defeat COVID-19, even as you confronted its destructive effects, our alliance members – you – stepped up. While Research!America advocacy and communications efforts redoubled in 2020 (40 letters and 7,000 emails to Congress; 141 meetings with congressional offices; and a more than five-fold...
Dear Research Advocate, “We are in the profession that aims to come up with answers. We have a mission and a noble one. I often like to point out while our initials are NIH….in circumstances like this we’re the National Institutes of Hope. While fear, anxiety, and stress are all around us, hope can be contagious.” —Francis Collins, MD, PhD Earlier today, Dr. Francis Collins, Director of the National Institutes of Health (NIH), joined us on our alliance member call to provide an overview of NIH’s unprecedented Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) , a partnership between industry and governmental leaders working to speed COVID-19 vaccines and treatments. Dr...
In January 2021, Research!America commissioned a survey seeking the opinions of Americans on federal support for current research efforts. When asked about the importance of elected officials at all levels listening to advice from scientists, a strong majority (88%) of respondents say that it is “somewhat important” or “very important”. These results are consistent with previous surveys asking the same question. In 2020, the last time this question was asked, 90% of respondents said it was “somewhat important” or “very important” for elected officials at all levels listening to advice from scientists with 54% saying “very important”, 4% less than in 2021, and 36% saying “somewhat important...
Dear Research Advocate, Yesterday, we hosted a very popular webinar, Understanding the Landscape of COVID-19 Vaccine and Treatment R&D , featuring former FDA Commissioner Mark McClellan, Director of the Duke-Margolis Health Policy Center; Stefano Bertuzzi, CEO of the American Society for Microbiology; and former CDC Director Julie Gerberding, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health at Merck. All three are working tirelessly to combat COVID-19. In speaking about current public-private research efforts, Dr. Gerberding emphasized: “This is the time we need the most openness, the most transparency, and the...
Dear Research Advocate, This past Monday, CDC Director Dr. Robert Redfield was our guest for the first of two alliance member calls this week, stressing the roles we all have to play: “I think this is an all-of-the nation response, not just an all-government response…. There’s no doubt we're going to learn a lot of lessons. But, I am 100 percent confident when we get to the other side, we're going to be so much stronger.” We are grateful to Director Redfield for spending time with us. Read more here . Innovation is key : Dr. Redfield repeatedly called for innovation: “I look forward to the innovation that we’re going to see from many of [Research!America’s] members to improve the tools we...

Pages